Other non-motor disorders in Parkinson's disease;Otros trastornos no motores en la enfermedad de Parkinson

Revista de Neurologia

Volumn 50, Issue SUPPL. 2, 2010, Pages

  Marco Llorente, Javier ^a   Rojo Martínez, Esther ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Dyspnea; Fatigue; Hyperhidrosis; Seborrheic dermatitis; Stridor; Weight loss

Indexed keywords

APOMORPHINE; BOTULINUM TOXIN; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; TESTOSTERONE;

ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; COMORBIDITY; DYSPNEA; DYSTONIA; EVALUATION; FATIGUE; HUMAN; LARYNX SPASM; LOW DRUG DOSE; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PREVALENCE; QUALITY OF LIFE; SEBORRHEIC DERMATITIS; STRIDOR; SWEATING; WEIGHT REDUCTION;

AUTONOMIC NERVOUS SYSTEM DISEASES; DERMATITIS, SEBORRHEIC; DOPAMINE AGENTS; FATIGUE; HUMANS; HYPERHIDROSIS; PARKINSON DISEASE; RESPIRATORY SOUNDS; WEIGHT LOSS;

EID: 77949533568     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Stiefler G. Die Seborrhoea faciei als ein symptom der encephalitis lethargica. Z Neurol Psychiatr 1921; 73: 455-63.
2. Krestin D. The seborrhoeic facies as a manifestation of postencephalitic parkinsonism and allied disorders. Q J Med 1927; 21: 177-86.
3. Weidman FB. Seborrhoeic dermatitis in a series of cases of postepidemic encephalitis. A M A Arch Derm 1930; 21: 690-1.
4. O'Neill CJ, Richardson MD, Charlett A, McHugh L, Bowes SG, Purkiss AG, et al. Could seborrhoeic dermatitis be implicated in the pathogenesis of parkinsonism? Acta Neurol Scand 1994; 89: 252-7.
5. Mastrolonardo M, Diaferio A, Logroscino G. Seborrheic dermatitis, increased sebum excretion, and Parkinson's disease: a survey of (im)possible links. Med Hypotheses 2003; 60: 907-11.
6. Fischer M, Gemende I, Marsch WC, Fischer PA. Skin function and skin disorders in Parkinson's disease. J Neural Transm 2001; 108: 205-13.
7. Pursiainen V, Haapaniemi TH, Korpelainen JT, Sotaniemi KA, Myllylä VV. Sweating in Parkinsonian patients with wearing-off. Mov Disord 2007; 22: 828-32.
8. Schestatsky P, Valls-Solé J, Ehlers JA, Rieder CR, Gomes I. Hyperhidrosis in Parkinson's disease. Mov Disord 2006; 21: 1744-8.
9. Schestatsky P, Ehlers JA, Rieder CR, Gomes I. Evaluation of sympathetic skin response in Parkinson's disease. Parkinsonism Relat Disord 2006; 12: 486-91.
10. Hirayama M. Sweating dysfunctions in Parkinson's disease. J Neurol 2006; 253 (Suppl 7): VII/42-7.
11. Uc EY, Struck LK, Rodnitzky RL, Zimmerman B, Dobson J, Evans WJ. Predictors of weight loss in Parkinson's disease. Mov Disord 2006; 21: 930-6.
12. Kashihara K. Weight loss in Parkinson's disease. J Neurol 2006; 253 (Suppl 7): VII/38-41.
13. Broussolle E, Borson F, González de Suso JM, Chayvialle JA, Beylot M, Chazot C. Augmentation de la dépense énergétique au cours de la maladie de Parkinson. Rev Neurol (Paris) 1991; 147: 46-51.
14. Markus HS, Cox M, Tomkins AM. Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity. Clin Sci 1992; 83: 199-204.
15. Jankovic J, Wooten M, Van der Linden C, Hansson B. Low body weight in Parkinson's disease. Southern Med J 1992; 83: 351-4.
16. Teasdale N, Hue O, Simoneau M, Tremblay A, Marceau P, Marceau S. Predictors of weight loss in Parkinson's disease: is weight loss the chicken or the egg? Mov Disord 2007; 22: 436-7.
17. Ondo WG, Ben-Aire L, Jankovic J, Lai E, Contant C, Grossman R. Weight gain following unilateral pallidotomy in Parkinson's disease. Acta Neurol Scand 2000; 101: 79-84.
18. Tuite PJ, Maxwell RE, Ikramuddin S, Kotz CM, Billington CJ, Thielen SD. Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery. Parkinsonism Relat Disord 2005; 11: 247-52.
19. Aziz NA, Van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, Roos RA. Weight loss in neurodegenerative disorders. J Neurol 2008; 255: 1872-80.
20. Friedman JH, Friedman H. Fatigue in Parkinson's disease. Neurology 1993; 43: 2016-8.
21. Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou JS, et al. Fatigue in Parkinson's disease: a review. Mov Disord 2007; 22: 297-308.
22. Yoshii F, Takahashi H, Kumazawa R, Kobori S. Parkinson's disease and fatigue. J Neurol 2006; 253 (Suppl 7) VII/48-53.
23. Abe K, Takanashi M, Yanagihara T. Fatigue in patients with Parkinson's disease. Behav Neurol 2000; 12: 103-6.
24. Shulman LM, Taback R, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 193-7.
25. Lou JS. Physical and mental fatigue in Parkinson's disease. Epidemiology, pathophysiology and treatment. Drugs Aging 2009; 26: 195-208.
26. Martínez-Martín P, Catalán MJ, Benito-León J, Moreno AO, Zamarbide I, Cubo E, et al. Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS). Qual Life Res 2006; 15: 597-606.
27. Shulman LM, Taback RL, Bean J, Weinr WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001; 16: 507-10.
28. Havlikova E, Van Dijk JP, Rosenberger J, Nagyova I, Middel B, Dubayova T, et al. Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleep. J Neurol Sci 2008; 270: 107-13.
29. Havlikova E, Rosenberger J, Nagyova I, Middel B, Dubayova T, Gdovinova Z, et al. Impact of fatigue on quality of life in patients with Parkinson's disease. Eur J Neurol 2008; 15: 475-80.
30. Oved D, Ziv I, Treves TA, Paleacu D, Melamed E, Djaldetti R. Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease. Mov Disord 2006; 21: 1257-61.
31. Mendonça DA, Menezes K, Jog MS. Methylphenidate improves fatigue scores in Parkinson's disease: a randomized controlled trial. Mov Disord 2007; 22: 2070-6.
32. Okun MS, Fernández HH, Rodríguez RL, Romrell J, Suelter M, Munson S, et al. Testosterone therapy in men with Parkinson's disease: results of the TEST-PD Study. Arch Neurol 2006; 63: 729-35.
33. Jiménez-Jiménez FJ, Izquierdo-Alonso JL. Alteraciones respiratorias en los trastornos del movimiento. Med Clin (Barc) 1996; 107: 342-6.
34. Inzelberg R, Peleg N, Nisipeanu P, Magadle R, Carasso RL, Weiner P. Inspiratory muscle training and the perception of dyspnea in Parkinson's disease. Can J Neurol Sci 2005; 32: 213-7.
35. Weiner P, Inzelberg R, Davidovich A, Nisipeaun P, Magadle R, Berar-Yanay N, et al. Respiratory muscle performance and the perception of dyspnea in Parkinson's disease. Can J Neurol Sci 2002; 29: 68-72.
36. Brescia-Mora V, Polverino M, De Luca G, Landi P, Galdi A, Campanella G. Upper airway muscles dysfunction and levodopa responsiveness in Parkinson's disease. Acta Neurol (Napoli) 1992; 14: 512-8.
37. De Bruin PF, De Bruin VM, Lees AJ, Pride WB. Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson's disease. Am Rev Respir Dis 1993; 148: 1576-80.
38. Santamaría J, Iranzo A, Tolosa E. Sleep disorders in multiple system atrophy. Neurología 2004; 19: 307-11.
39. Yamaguchi M, Arai K, Asahina M, Hattori T. Laryngeal stridor in multiple system atrophy. Eur Neurol 2003; 49: 154-9.
40. Isozaki E, Shimizu T, Takamoto K, Horiguchi S, Hayashida T, Oda M, et al. Vocal cord abductor paralysis (VCAP) in Parkinson's disease: difference from VCAP in multiple system atrophy. J Neurol Sci 1995; 130: 197-202.
41. Read D, Young A. Stridor and parkinsonism. Postgrad Med J 1983; 59: 520-1.
42. Corbin DO, Williams AC. Stridor during dystonic phases of Parkinson's disease. J Neurol Neurosurg Psychiatry 1987; 50: 821-2.
43. Gdynia HJ, Kassubek J, Sperfeld AD. Laryngospasm in neurological diseases. Neurocrit Care 2006; 4: 163-7.
44. Isozaki E, Hayashi M, Hayashida T, Oda M, Hirai S. Myopathology of the intrinsic laryngeal muscles in neurodegenerative diseases, with reference to the mechanism of vocal cord paralysis. Rinsho Shinkeigaku 1998; 38: 711-8.